| 1 | INS, MODY10
|
| Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY).
|
| Boesgaard TW, Pruhova S, Andersson EA, Cinek O, Obermannova B, Lauenborg J, Damm P, Bergholdt R, Pociot F, Pisinger C, Barbetti F, Lebl J, Pedersen O, Hansen T.
|
| BMC Med Genet 11:42.PMID: 20226046 2010
|
| 2 | CLEC16A, CTLA4, IFIH1, IL2RA, INS, MODY10, PTPN2, PTPN22
|
| The molecular genetics of type 1 diabetes: new genes and emerging mechanisms.
|
| Ounissi-Benkalha H, Polychronakos C.
|
| Trends Mol Med 14(6):268-75. Epub 2008 May 14. 2008
|
| 3 | AGT, INS, MAPK7, MODY10
|
| Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells.
|
| Sharma G, Goalstone ML.
|
| Biochem Biophys Res Commun 354(4):1078-83. Epub 2007 Jan 26. 2007
|
| 4 | INS, MODY10, PNDM4
|
| Insulin gene mutations as a cause of permanent neonatal diabetes.
|
| Stoy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, Below JE, Hayes MG, Cox NJ, Lipkind GM, Lipton RB, Greeley SA, Patch AM, Ellard S, Steiner DF, Hattersley AT, Philipson LH, Bell GI; Neonatal Diabetes International Collaborative Group.
|
| Proc Natl Acad Sci U S A 104(38):15040-4. Epub 2007 Sep 12. 2007
|
| 5 | INS, MODY10
|
| Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity.
|
| Le Stunff C, Fallin D, Bougneres P.
|
| Nat Genet 29(1):96-9. 2001
|
| 6 | INS, MODY10
|
| The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity.
|
| Le Stunff C, Fallin D, Schork NJ, Bougneres P.
|
| Nat Genet 26(4):444-6. 2000
|
| 7 | IGF2, INS, MODY10
|
| Associations of IGF2 apaI RFLP and INS VNTR class I allele size with obesity.
|
| O'Dell SD, et al.
|
| Eur J Hum Genet 7(7):821-7 1999
|
| 8 | IDDM2, INS, MODY10
|
| The insulin gene VNTR, type 2 diabetes and birth weight.
|
| Ong KK, Phillips DI, Fall C, Poulton J, Bennett ST, Golding J, Todd JA, Dunger DB.
|
| Nat Genet 21(3):262-3. No abstract available. 1999
|
| 9 | INS, MODY10
|
| Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin : identification of the mutation by restriction enzyme mapping.
|
| Collinet M, et al.
|
| Eur J Pediatr 157 : 456-460. 1998
|
| 10 | IDDM2, INS, MODY10
|
| The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.
|
| Pugliese A, et al.
|
| Nat Genet 15 : 293-297. 1997
|
| 11 | IDDM2, INS, MODY10
|
| Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.
|
| Vafiadis P, et al.
|
| Nat Genet 15 : 289-292. 1997
|
| 12 | INS, MODY10
|
| A novel point mutation in the insulin gene giving rise to hyperproinsulinemia.
|
| Warren-Perry MG, et al.
|
| J Clin Endocrinol Metab 82 : 1629-1631. 1997
|
| 13 | IDDM2, INS, MODY10
|
| Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype.
|
| Lucassen AM, et al.
|
| Hum Mol Genet 4 : 501-506. 1995
|
| 14 | INS, MODY10
|
| A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).
|
| Yano H, et al.
|
| J Clin Invest 89 : 1902-1907. 1992
|
| 15 | INS, MODY10
|
| A variant insulin promoter in non-insulin-dependent diabetes mellitus.
|
| Olansky L, et al.
|
| J Clin Invest 89 : 1596-1602. 1992
|
| 16 | INS, MODY10
|
| Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule : identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction.
|
| Barbetti F, et al.
|
| J Clin Endocrinol Metab 71 : 164-169. 1990
|
| 17 | HB-NA@, HBB, HBBP1, HBD, HBE1, HBG1, HBG2, HRAS, INS, MODY10, PTH
|
| Germ-line chromosomal localization of genes in chromosome 11p linkage: parathyroid hormone, beta-globin, c-H-ras-1, and insulin.
|
| Chaganti RSK, et al.
|
| Somat Cell Mol Genet 11 : 197-202. 1985
|
| 18 | INS, MODY10
|
| Familial hyperinsulinemia due to a structurally abnormal insulin.
|
| Haneda M, et al.
|
| N Engl J Med 310 : 1288-1294. 1984
|